{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T10:43:13Z","timestamp":1777632193564,"version":"3.51.4"},"reference-count":199,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2015,4,16]],"date-time":"2015-04-16T00:00:00Z","timestamp":1429142400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1007\/s00204-015-1513-x","type":"journal-article","created":{"date-parts":[[2015,4,15]],"date-time":"2015-04-15T06:23:27Z","timestamp":1429079007000},"page":"1151-1173","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":195,"title":["The hallucinogenic world of tryptamines: an updated review"],"prefix":"10.1007","volume":"89","author":[{"given":"Ana Margarida","family":"Ara\u00fajo","sequence":"first","affiliation":[]},{"given":"F\u00e9lix","family":"Carvalho","sequence":"additional","affiliation":[]},{"given":"Maria de Lourdes","family":"Bastos","sequence":"additional","affiliation":[]},{"given":"Paula","family":"Guedes de Pinho","sequence":"additional","affiliation":[]},{"given":"M\u00e1rcia","family":"Carvalho","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2015,4,16]]},"reference":[{"issue":"2","key":"1513_CR1","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0278-5846(85)90074-0","volume":"9","author":"LM Adams","year":"1985","unstructured":"Adams LM, Geyer MA (1985a) Effects of DOM and DMT in a proposed animal model of hallucinogenic activity. Prog Neuropsychopharmacol Biol Psychiatry 9(2):121\u2013132","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"5","key":"1513_CR2","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1037\/0735-7044.99.5.881","volume":"99","author":"LM Adams","year":"1985","unstructured":"Adams LM, Geyer MA (1985b) A proposed animal model for hallucinogens based on LSD\u2019s effects on patterns of exploration in rats. Behav Neurosci 99(5):881\u2013900","journal-title":"Behav Neurosci"},{"issue":"4","key":"1513_CR3","doi-asserted-by":"crossref","first-page":"550","DOI":"10.4065\/81.4.550","volume":"81","author":"G Alatrash","year":"2006","unstructured":"Alatrash G, Majhail NS, Pile JC (2006) Rhabdomyolysis after ingestion of \u201cfoxy,\u201d a hallucinogenic tryptamine derivative. Mayo Clin Proc 81(4):550\u2013551. doi: 10.4065\/81.4.550","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"1513_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1476-5381.1968.tb07943.x","volume":"34","author":"NE Anden","year":"1968","unstructured":"Anden NE, Corrodi H, Fuxe K, Hokfelt T (1968) Evidence for a central 5-hydroxytryptamine receptor stimulation by lysergic acid diethylamide. Br J Pharmacol 34(1):1\u20137","journal-title":"Br J Pharmacol"},{"issue":"1","key":"1513_CR5","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0014-2999(89)90041-1","volume":"159","author":"JB Appel","year":"1989","unstructured":"Appel JB, Callahan PM (1989) Involvement of 5-HT receptor subtypes in the discriminative stimulus properties of mescaline. Eur J Pharmacol 159(1):41\u201346","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"1513_CR6","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.drugalcdep.2011.10.007","volume":"122","author":"MD Arbo","year":"2012","unstructured":"Arbo MD, Bastos ML, Carmo HF (2012) Piperazine compounds as drugs of abuse. Drug Alcohol Depend 122(3):174\u2013185. doi: 10.1016\/j.drugalcdep.2011.10.007","journal-title":"Drug Alcohol Depend"},{"issue":"11","key":"1513_CR7","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1039\/c2np20068f","volume":"29","author":"W Arunotayanun","year":"2012","unstructured":"Arunotayanun W, Gibbons S (2012) Natural product \u2018legal highs\u2019. Nat Prod Rep 29(11):1304\u20131316. doi: 10.1039\/c2np20068f","journal-title":"Nat Prod Rep"},{"issue":"2","key":"1513_CR8","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.cpem.2005.04.002","volume":"6","author":"K Babu","year":"2005","unstructured":"Babu K, Boyer EW, Hernon C, Brush DE (2005) Emerging drugs of abuse. Clin Pediatr Emerg Med 6(2):81\u201384. doi: 10.1016\/j.cpem.2005.04.002","journal-title":"Clin Pediatr Emerg Med"},{"issue":"2","key":"1513_CR9","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0378-8741(84)90007-2","volume":"10","author":"ER Badham","year":"1984","unstructured":"Badham ER (1984) Ethnobotany of psilocybin mushrooms, especially Psilocybe cubensis. J Ethnopharmacol 10(2):249\u2013254","journal-title":"J Ethnopharmacol"},{"issue":"7","key":"1513_CR10","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/0006-2952(80)90169-0","volume":"29","author":"SA Barker","year":"1980","unstructured":"Barker SA, Monti JA, Christian ST (1980) Metabolism of the hallucinogen N,N-dimethyltryptamine in rat brain homogenates. Biochem Pharmacol 29(7):1049\u20131057","journal-title":"Biochem Pharmacol"},{"issue":"7\u20138","key":"1513_CR11","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/dta.422","volume":"4","author":"SA Barker","year":"2012","unstructured":"Barker SA, McIlhenny EH, Strassman R (2012) A critical review of reports of endogenous psychedelic N,N-dimethyltryptamines in humans: 1955\u20132010. Drug Test Anal 4(7\u20138):617\u2013635. doi: 10.1002\/dta.422","journal-title":"Drug Test Anal"},{"issue":"4","key":"1513_CR12","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1007\/s00213-004-2108-z","volume":"179","author":"MA Benneyworth","year":"2005","unstructured":"Benneyworth MA, Smith RL, Barrett RJ, Sanders-Bush E (2005) Complex discriminative stimulus properties of (+)lysergic acid diethylamide (LSD) in C57Bl\/6J mice. Psychopharmacology 179(4):854\u2013862. doi: 10.1007\/s00213-004-2108-z","journal-title":"Psychopharmacology"},{"issue":"6","key":"1513_CR13","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1080\/15563650903037181","volume":"47","author":"K Bjornstad","year":"2009","unstructured":"Bjornstad K, Hulten P, Beck O, Helander A (2009) Bioanalytical and clinical evaluation of 103 suspected cases of intoxications with psychoactive plant materials. Clin Toxicol 47(6):566\u2013572. doi: 10.1080\/15563650903037181","journal-title":"Clin Toxicol"},{"issue":"24","key":"1513_CR14","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.1021\/jm000339w","volume":"43","author":"JB Blair","year":"2000","unstructured":"Blair JB, Kurrasch-Orbaugh D, Marona-Lewicka D et al (2000) Effect of ring fluorination on the pharmacology of hallucinogenic tryptamines. J Med Chem 43(24):4701\u20134710","journal-title":"J Med Chem"},{"issue":"5","key":"1513_CR15","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1093\/jat\/29.5.394","volume":"29","author":"DM Boland","year":"2005","unstructured":"Boland DM, Andollo W, Hime GW, Hearn WL (2005) Fatality due to acute alpha-methyltryptamine intoxication. J Anal Toxicol 29(5):394\u2013397","journal-title":"J Anal Toxicol"},{"issue":"4","key":"1513_CR16","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jpba.2004.08.022","volume":"36","author":"SD Brandt","year":"2004","unstructured":"Brandt SD, Freeman S, McGagh P, Abdul-Halim N, Alder JF (2004) An analytical perspective on favoured synthetic routes to the psychoactive tryptamines. J Pharm Biomed Anal 36(4):675\u2013691. doi: 10.1016\/j.jpba.2004.08.022","journal-title":"J Pharm Biomed Anal"},{"issue":"5","key":"1513_CR17","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0028-3908(67)90034-2","volume":"6","author":"RW Brimblecombe","year":"1967","unstructured":"Brimblecombe RW (1967) Hyperthermic effects of some tryptamine derivatives in relation to their behavioral activity. Int J Neuropharmacol 6(5):423\u2013429","journal-title":"Int J Neuropharmacol"},{"issue":"2","key":"1513_CR18","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1081\/CLT-120030949","volume":"42","author":"DE Brush","year":"2004","unstructured":"Brush DE, Bird SB, Boyer EW (2004) Monoamine oxidase inhibitor poisoning resulting from Internet misinformation on illicit substances. J Toxicol Clin Toxicol 42(2):191\u2013195","journal-title":"J Toxicol Clin Toxicol"},{"issue":"2","key":"1513_CR19","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/02791072.2008.10400630","volume":"40","author":"RK Bullis","year":"2008","unstructured":"Bullis RK (2008) The \u201cvine of the soul\u201d vs. the controlled substances act: implications of the hoasca case. J Psychoact Drugs 40(2):193\u2013199. doi: 10.1080\/02791072.2008.10400630","journal-title":"J Psychoact Drugs"},{"issue":"6","key":"1513_CR20","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1124\/mol.60.6.1181","volume":"60","author":"JR Bunzow","year":"2001","unstructured":"Bunzow JR, Sonders MS, Arttamangkul S et al (2001) Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor. Mol Pharmacol 60(6):1181\u20131188","journal-title":"Mol Pharmacol"},{"issue":"1\u20132","key":"1513_CR21","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.drugalcdep.2010.03.015","volume":"111","author":"V Cakic","year":"2010","unstructured":"Cakic V, Potkonyak J, Marshall A (2010) Dimethyltryptamine (DMT): subjective effects and patterns of use among Australian recreational users. Drug Alcohol Depend 111(1\u20132):30\u201337. doi: 10.1016\/j.drugalcdep.2010.03.015","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"1513_CR22","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/S0022-3565(25)12637-2","volume":"254","author":"CW Callaway","year":"1990","unstructured":"Callaway CW, Wing LL, Geyer MA (1990) Serotonin release contributes to the locomotor stimulant effects of 3,4-methylenedioxymethamphetamine in rats. J Pharmacol Exp Ther 254(2):456\u2013464","journal-title":"J Pharmacol Exp Ther"},{"issue":"6","key":"1513_CR23","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/jat\/20.6.492","volume":"20","author":"JC Callaway","year":"1996","unstructured":"Callaway JC, Raymon LP, Hearn WL et al (1996) Quantitation of N,N-dimethyltryptamine and harmala alkaloids in human plasma after oral dosing with ayahuasca. J Anal Toxicol 20(6):492\u2013497","journal-title":"J Anal Toxicol"},{"issue":"2","key":"1513_CR24","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00213-012-2891-x","volume":"226","author":"TM Carbonaro","year":"2013","unstructured":"Carbonaro TM, Forster MJ, Gatch MB (2013) Discriminative stimulus effects of N,N-diisopropyltryptamine. Psychopharmacology 226(2):241\u2013246. doi: 10.1007\/s00213-012-2891-x","journal-title":"Psychopharmacology"},{"key":"1513_CR25","first-page":"1","volume":"6","author":"RP Chamakura","year":"1994","unstructured":"Chamakura RP (1994) Bufotenine\u2014a hallucinogen in ancient snuff powders of South America and a drug of abuse on the streets of New York City. Forensic Sci Rev 6:1\u201318","journal-title":"Forensic Sci Rev"},{"issue":"2","key":"1513_CR26","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/0006-2944(77)90088-6","volume":"18","author":"ST Christian","year":"1977","unstructured":"Christian ST, Harrison R, Quayle E, Pagel J, Monti J (1977) The in vitro identification of dimethyltryptamine (DMT) in mammalian brain and its characterization as a possible endogenous neuroregulatory agent. Biochem Med 18(2):164\u2013183","journal-title":"Biochem Med"},{"issue":"9\u201310","key":"1513_CR27","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1081\/JA-200066898","volume":"40","author":"MC Clatts","year":"2005","unstructured":"Clatts MC, Goldsamt LA, Yi H (2005) Club drug use among young men who have sex with men in NYC: a preliminary epidemiological profile. Subst Use Misuse 40(9\u201310):1317\u20131330. doi: 10.1081\/JA-200066898","journal-title":"Subst Use Misuse"},{"issue":"1","key":"1513_CR28","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S0022-3565(25)33038-7","volume":"221","author":"FC Colpaert","year":"1982","unstructured":"Colpaert FC, Niemegeers CJ, Janssen PA (1982) A drug discrimination analysis of lysergic acid diethylamide (LSD): in vivo agonist and antagonist effects of purported 5-hydroxytryptamine antagonists and of pirenperone, a LSD-antagonist. J Pharmacol Exp Ther 221(1):206\u2013214","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"1513_CR29","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.physbeh.2011.01.021","volume":"103","author":"DM Compton","year":"2011","unstructured":"Compton DM, Dietrich KL, Selinger MC, Testa EK (2011) 5-methoxy-N,N-di(iso)propyltryptamine hydrochloride (Foxy)-induced cognitive deficits in rat after exposure in adolescence. Physiol Behav 103(2):203\u2013209. doi: 10.1016\/j.physbeh.2011.01.021","journal-title":"Physiol Behav"},{"issue":"2","key":"1513_CR30","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.pnpbp.2012.05.022","volume":"39","author":"JM Corkery","year":"2012","unstructured":"Corkery JM, Durkin E, Elliott S, Schifano F, Ghodse AH (2012) The recreational tryptamine 5-MeO-DALT (N,N-diallyl-5-methoxytryptamine): a brief review. Prog Neuropsychopharmacol Biol Psychiatry 39(2):259\u2013262. doi: 10.1016\/j.pnpbp.2012.05.022","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"12","key":"1513_CR31","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1007\/s00702-009-0308-8","volume":"116","author":"NV Cozzi","year":"2009","unstructured":"Cozzi NV, Gopalakrishnan A, Anderson LL et al (2009) Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporter. J Neural Transm 116(12):1591\u20131599. doi: 10.1007\/s00702-009-0308-8","journal-title":"J Neural Transm"},{"issue":"2","key":"1513_CR32","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1742-6723.2008.01070.x","volume":"20","author":"N Cunningham","year":"2008","unstructured":"Cunningham N (2008) Hallucinogenic plants of abuse. Emerg Med Australas 20(2):167\u2013174. doi: 10.1111\/j.1742-6723.2008.01070.x","journal-title":"Emerg Med Australas"},{"issue":"1","key":"1513_CR33","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/BF00690929","volume":"91","author":"KA Cunningham","year":"1987","unstructured":"Cunningham KA, Appel JB (1987) Neuropharmacological reassessment of the discriminative stimulus properties of d-lysergic acid diethylamide (LSD). Psychopharmacology 91(1):67\u201373","journal-title":"Psychopharmacology"},{"key":"1513_CR34","first-page":"126","volume":"34","author":"Drug Enforcement Administration DoJ","year":"2001","unstructured":"Drug Enforcement Administration DoJ (2001) An encounter with 5-methoxy-N,N-diisopropyltryptamine. Microgram Bull 34:126","journal-title":"Microgram Bull"},{"issue":"65","key":"1513_CR35","first-page":"16427","volume":"68","author":"Drug Enforcement Administration DoJ","year":"2003","unstructured":"Drug Enforcement Administration DoJ (2003) Schedules of controlled substances: temporary placement of alpha-methyltryptamine and 5-methoxy-N,N-diisopropyltryptamine into Schedule I. Final rule. Fed Regist 68(65):16427\u201316430","journal-title":"Fed Regist"},{"issue":"188","key":"1513_CR36","first-page":"58950","volume":"69","author":"Drug Enforcement Administration DoJ","year":"2004","unstructured":"Drug Enforcement Administration DoJ (2004) Schedules of controlled substances: placement of alpha-methyltryptamine and 5-methoxy-N,N-diisopropyltryptamine into Schedule I of the Controlled Substances Act. Final rule. Fed Regist 69(188):58950\u201358953","journal-title":"Fed Regist"},{"key":"1513_CR49","unstructured":"Drugs Forum (2010) 5-MeO-DALT. Available at http:\/\/www.drugs-forum.com\/forum\/showwiki.php?title=5-MeODALT"},{"key":"1513_CR37","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0022-3565(25)26298-X","volume":"136","author":"J Elder","year":"1962","unstructured":"Elder J, Shellehberger M (1962) Antagonism of lysergic acid diethylamide (LSD) induced hyperthermia. J Pharmacol Exp Ther 136:293\u2013297","journal-title":"J Pharmacol Exp Ther"},{"issue":"7\u20138","key":"1513_CR38","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/dta.307","volume":"3","author":"S Elliott","year":"2011","unstructured":"Elliott S (2011) Current awareness of piperazines: pharmacology and toxicology. Drug Test Anal 3(7\u20138):430\u2013438. doi: 10.1002\/dta.307","journal-title":"Drug Test Anal"},{"key":"1513_CR39","unstructured":"EMCDDA (2010) Annual report on the state of the drugs problem in Europe. Euro Surveill. doi: 10.2810\/33349 . http:\/\/www.emcdda.europa.eu\/"},{"key":"1513_CR40","unstructured":"EMCDDA (2012) The EMCDDA annual report 2012: the state of the drugs problem in Europe. Euro Surveill. doi: 10.2810\/64775 . http:\/\/www.emcdda.europa.eu\/"},{"key":"1513_CR41","unstructured":"EMCDDA (2014) European drug report 2014: trends and developments. Euro Surveill. doi: 10.2810\/32306 . http:\/\/www.emcdda.europa.eu\/"},{"issue":"1","key":"1513_CR42","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1113\/jphysiol.1955.sp005242","volume":"127","author":"V Erspamer","year":"1955","unstructured":"Erspamer V (1955) Observations on the fate of indolalkylamines in the organism. J Physiol 127(1):118\u2013133","journal-title":"J Physiol"},{"issue":"1","key":"1513_CR43","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.pbb.2005.12.015","volume":"83","author":"WE Fantegrossi","year":"2006","unstructured":"Fantegrossi WE, Harrington AW, Kiessel CL et al (2006) Hallucinogen-like actions of 5-methoxy-N,N-diisopropyltryptamine in mice and rats. Pharmacol Biochem Behav 83(1):122\u2013129. doi: 10.1016\/j.pbb.2005.12.015","journal-title":"Pharmacol Biochem Behav"},{"issue":"1","key":"1513_CR44","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.bcp.2007.07.018","volume":"75","author":"WE Fantegrossi","year":"2008","unstructured":"Fantegrossi WE, Murnane KS, Reissig CJ (2008a) The behavioral pharmacology of hallucinogens. Biochem Pharmacol 75(1):17\u201333. doi: 10.1016\/j.bcp.2007.07.018","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"1513_CR45","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.pbb.2007.09.007","volume":"88","author":"WE Fantegrossi","year":"2008","unstructured":"Fantegrossi WE, Reissig CJ, Katz EB, Yarosh HL, Rice KC, Winter JC (2008b) Hallucinogen-like effects of N,N-dipropyltryptamine (DPT): possible mediation by serotonin 5-HT1A and 5-HT2A receptors in rodents. Pharmacol Biochem Behav 88(3):358\u2013365. doi: 10.1016\/j.pbb.2007.09.007","journal-title":"Pharmacol Biochem Behav"},{"key":"1513_CR46","doi-asserted-by":"crossref","first-page":"5892","DOI":"10.1021\/ja01627a034","volume":"77","author":"MS Fish","year":"1955","unstructured":"Fish MS, Johnson NM, Horning EC (1955a) Piptadenia alkaloids. Indole bases of Piptadenia peregrina (L) Benth and related species. J Am Chem Soc 77:5892\u20135895","journal-title":"J Am Chem Soc"},{"issue":"4","key":"1513_CR47","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/0006-3002(55)90150-5","volume":"18","author":"MS Fish","year":"1955","unstructured":"Fish MS, Johnson NM, Lawrence EP, Horning EC (1955b) Oxidative N-dealkylation. Biochim Biophys Acta 18(4):564\u2013565","journal-title":"Biochim Biophys Acta"},{"issue":"5916","key":"1513_CR48","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1126\/science.1166127","volume":"323","author":"D Fontanilla","year":"2009","unstructured":"Fontanilla D, Johannessen M, Hajipour AR, Cozzi NV, Jackson MB, Ruoho AE (2009) The hallucinogen N,N-dimethyltryptamine (DMT) is an endogenous sigma-1 receptor regulator. Science 323(5916):934\u2013937. doi: 10.1126\/science.1166127","journal-title":"Science"},{"issue":"988","key":"1513_CR50","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/2061052a0","volume":"206","author":"F Franzen","year":"1965","unstructured":"Franzen F, Gross H (1965) Tryptamine, N,N-dimethyltryptamine, N,N-dimethyl-5-hydroxytryptamine and 5-methoxytryptamine in human blood and urine. Nature 206(988):1052","journal-title":"Nature"},{"issue":"7","key":"1513_CR51","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0223-5234(02)01382-X","volume":"37","author":"S Freeman","year":"2002","unstructured":"Freeman S, Alder JF (2002) Arylethylamine psychotropic recreational drugs: a chemical perspective. Eur J Med Chem 37(7):527\u2013539","journal-title":"Eur J Med Chem"},{"issue":"1","key":"1513_CR52","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1940-0640-8-9","volume":"8","author":"Y Fuse-Nagase","year":"2013","unstructured":"Fuse-Nagase Y, Nishikawa T (2013) Prolonged delusional state triggered by repeated ingestion of aromatic liquid in a past 5-methoxy-N,N-diisopropyltryptamine abuser. Addict Sci Clin Pract 8(1):9. doi: 10.1186\/1940-0640-8-9","journal-title":"Addict Sci Clin Pract"},{"issue":"1","key":"1513_CR53","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1360-0443.2006.01652.x","volume":"102","author":"RS Gable","year":"2007","unstructured":"Gable RS (2007) Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids. Addiction 102(1):24\u201334. doi: 10.1111\/j.1360-0443.2006.01652.x","journal-title":"Addiction"},{"issue":"4","key":"1513_CR54","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s00213-009-1501-z","volume":"204","author":"MB Gatch","year":"2009","unstructured":"Gatch MB, Rutledge MA, Carbonaro T, Forster MJ (2009) Comparison of the discriminative stimulus effects of dimethyltryptamine with different classes of psychoactive compounds in rats. Psychopharmacology 204(4):715\u2013724. doi: 10.1007\/s00213-009-1501-z","journal-title":"Psychopharmacology"},{"issue":"1","key":"1513_CR55","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/BF00491975","volume":"65","author":"MA Geyer","year":"1979","unstructured":"Geyer MA, Light RK, Rose GJ et al (1979) A characteristic effect of hallucinogens on investigatory responding in rats. Psychopharmacology 65(1):35\u201340","journal-title":"Psychopharmacology"},{"issue":"1","key":"1513_CR56","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3109\/15563650.2011.645952","volume":"50","author":"S Gibbons","year":"2012","unstructured":"Gibbons S (2012) \u2018Legal highs\u2019-novel and emerging psychoactive drugs: a chemical overview for the toxicologist. Clin Toxicol 50(1):15\u201324. doi: 10.3109\/15563650.2011.645952","journal-title":"Clin Toxicol"},{"issue":"9","key":"1513_CR57","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/0024-3205(86)90461-3","volume":"39","author":"RA Glennon","year":"1986","unstructured":"Glennon RA (1986) Discriminative stimulus properties of the serotonergic agent 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI). Life Sci 39(9):825\u2013830","journal-title":"Life Sci"},{"key":"1513_CR58","doi-asserted-by":"crossref","unstructured":"Glennon RA (1996) Classical hallucinogens. In: Schuster CR, Kuhar MJ (eds) Pharmacological aspects of drug dependence. Handbook of experimental pharmacology, Springer, Basel, pp 343\u2013371","DOI":"10.1007\/978-3-642-60963-3_10"},{"issue":"11","key":"1513_CR59","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/0024-3205(79)90317-5","volume":"24","author":"RA Glennon","year":"1979","unstructured":"Glennon RA, Rosecrans JA, Young R, Gaines J (1979) Hallucinogens as a discriminative stimuli: generalization of DOM to a 5-methoxy-N,N-dimethyltryptamine stimulus. Life Sci 24(11):993\u2013997","journal-title":"Life Sci"},{"issue":"2\u20133","key":"1513_CR60","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0014-2999(83)90464-8","volume":"91","author":"RA Glennon","year":"1983","unstructured":"Glennon RA, Young R, Rosecrans JA (1983) Antagonism of the effects of the hallucinogen DOM and the purported 5-HT agonist quipazine by 5-HT2 antagonists. Eur J Pharmacol 91(2\u20133):189\u2013196","journal-title":"Eur J Pharmacol"},{"issue":"25","key":"1513_CR61","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1016\/0024-3205(84)90436-3","volume":"35","author":"RA Glennon","year":"1984","unstructured":"Glennon RA, Titeler M, McKenney JD (1984) Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents. Life Sci 35(25):2505\u20132511","journal-title":"Life Sci"},{"issue":"5","key":"1513_CR62","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1021\/jm00388a032","volume":"30","author":"RA Glennon","year":"1987","unstructured":"Glennon RA, Titeler M, Seggel MR, Lyon RA (1987) N-methyl derivatives of the 5-HT2 agonist 1-(4-bromo-2,5-dimethoxyphenyl)-2-aminopropane. J Med Chem 30(5):930\u2013932","journal-title":"J Med Chem"},{"issue":"10","key":"1513_CR63","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1021\/jm00172a016","volume":"33","author":"RA Glennon","year":"1990","unstructured":"Glennon RA, Chaurasia C, Titeler M (1990) Binding of indolylalkylamines at 5-HT2 serotonin receptors: examination of a hydrophobic binding region. J Med Chem 33(10):2777\u20132784","journal-title":"J Med Chem"},{"issue":"3","key":"1513_CR64","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.neuron.2007.01.008","volume":"53","author":"J Gonzalez-Maeso","year":"2007","unstructured":"Gonzalez-Maeso J, Weisstaub NV, Zhou M et al (2007) Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior. Neuron 53(3):439\u2013452. doi: 10.1016\/j.neuron.2007.01.008","journal-title":"Neuron"},{"key":"1513_CR65","unstructured":"Government P (2013) Decreto Lei no. 54\/2013. In: Justi\u00e7a Dd (ed). Di\u00e1rio da Rep\u00fablica 75"},{"issue":"2","key":"1513_CR66","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1124\/jpet.106.112946","volume":"320","author":"PJ Gresch","year":"2007","unstructured":"Gresch PJ, Barrett RJ, Sanders-Bush E, Smith RL (2007) 5-Hydroxytryptamine (serotonin)2A receptors in rat anterior cingulate cortex mediate the discriminative stimulus properties of d-lysergic acid diethylamide. J Pharmacol Exp Ther 320(2):662\u2013669. doi: 10.1124\/jpet.106.112946","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"1513_CR67","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1471-4159.1976.tb04456.x","volume":"26","author":"RB Guchhait","year":"1976","unstructured":"Guchhait RB (1976) Biogenesis of 5-methoxy-N,N-dimethyltryptamine in human pineal gland. J Neurochem 26(1):187\u2013190","journal-title":"J Neurochem"},{"issue":"Pt 1","key":"1513_CR68","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1042\/0264-6021:3430011","volume":"343","author":"B Gutsche","year":"1999","unstructured":"Gutsche B, Grun C, Scheutzow D, Herderich M (1999) Tryptophan glycoconjugates in food and human urine. Biochem J 343(Pt 1):11\u201319","journal-title":"Biochem J"},{"key":"1513_CR69","volume-title":"Mystic chemist: the life of Albert Hofmann and his discovery of LSD","author":"D Hagenbach","year":"2011","unstructured":"Hagenbach D, Werthmuller L (2011) Mystic chemist: the life of Albert Hofmann and his discovery of LSD. Synergetic Press, Santa Fe, New Mexico"},{"issue":"3","key":"1513_CR70","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.neuropharm.2011.01.017","volume":"61","author":"AL Halberstadt","year":"2011","unstructured":"Halberstadt AL, Geyer MA (2011) Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens. Neuropharmacology 61(3):364\u2013381. doi: 10.1016\/j.neuropharm.2011.01.017","journal-title":"Neuropharmacology"},{"key":"1513_CR71","doi-asserted-by":"crossref","unstructured":"Halberstadt A, Geyer M (2013) Neuropharmacology of lysergic acid diethylamide (LSD) and other hallucinogens. In: Miller P (ed) Biological research on addiction: comprehensive addictive behaviors and disorders, vol 2. Elsevier, London, pp 625\u2013635","DOI":"10.1016\/B978-0-12-398335-0.00061-3"},{"issue":"1","key":"1513_CR72","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00213-008-1247-z","volume":"201","author":"AL Halberstadt","year":"2008","unstructured":"Halberstadt AL, Buell MR, Masten VL, Risbrough VB, Geyer MA (2008) Modification of the effects of 5-methoxy-N,N-dimethyltryptamine on exploratory behavior in rats by monoamine oxidase inhibitors. Psychopharmacology 201(1):55\u201366. doi: 10.1007\/s00213-008-1247-z","journal-title":"Psychopharmacology"},{"issue":"11","key":"1513_CR73","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1177\/0269881110388326","volume":"25","author":"AL Halberstadt","year":"2011","unstructured":"Halberstadt AL, Koedood L, Powell SB, Geyer MA (2011) Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice. J Psychopharmacol 25(11):1548\u20131561. doi: 10.1177\/0269881110388326","journal-title":"J Psychopharmacol"},{"issue":"2","key":"1513_CR74","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.pharmthera.2004.03.003","volume":"102","author":"JH Halpern","year":"2004","unstructured":"Halpern JH (2004) Hallucinogens and dissociative agents naturally growing in the United States. Pharmacol Ther 102(2):131\u2013138. doi: 10.1016\/j.pharmthera.2004.03.003","journal-title":"Pharmacol Ther"},{"key":"1513_CR75","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/BF01864237","volume":"86","author":"H Handovsky","year":"1920","unstructured":"Handovsky H (1920) Ein Alkaloid in Gifte von Bufo vulgaris. Arch Exp Pathol Pharmacol 86:138\u2013158","journal-title":"Arch Exp Pathol Pharmacol"},{"issue":"3","key":"1513_CR76","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0031-6865(97)00014-9","volume":"72","author":"F Hasler","year":"1997","unstructured":"Hasler F, Bourquin D, Brenneisen R, Bar T, Vollenweider FX (1997) Determination of psilocin and 4-hydroxyindole-3-acetic acid in plasma by HPLC-ECD and pharmacokinetic profiles of oral and intravenous psilocybin in man. Pharm Acta Helv 72(3):175\u2013184","journal-title":"Pharm Acta Helv"},{"issue":"2","key":"1513_CR77","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0731-7085(02)00278-9","volume":"30","author":"F Hasler","year":"2002","unstructured":"Hasler F, Bourquin D, Brenneisen R, Vollenweider FX (2002) Renal excretion profiles of psilocin following oral administration of psilocybin: a controlled study in man. J Pharm Biomed Anal 30(2):331\u2013339","journal-title":"J Pharm Biomed Anal"},{"issue":"2","key":"1513_CR78","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00213-003-1640-6","volume":"172","author":"F Hasler","year":"2004","unstructured":"Hasler F, Grimberg U, Benz MA, Huber T, Vollenweider FX (2004) Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose-effect study. Psychopharmacology 172(2):145\u2013156. doi: 10.1007\/s00213-003-1640-6","journal-title":"Psychopharmacology"},{"issue":"4","key":"1513_CR79","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0278-5846(98)00031-1","volume":"22","author":"S Helsley","year":"1998","unstructured":"Helsley S, Fiorella D, Rabin RA, Winter JC (1998) A comparison of N,N-dimethyltryptamine, harmaline, and selected congeners in rats trained with LSD as a discriminative stimulus. Prog Neuropsychopharmacol Biol Psychiatry 22(4):649\u2013663","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"8","key":"1513_CR80","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3109\/15563650.2011.615318","volume":"49","author":"SL Hill","year":"2011","unstructured":"Hill SL, Thomas SH (2011) Clinical toxicology of newer recreational drugs. Clin Toxicol 49(8):705\u2013719. doi: 10.3109\/15563650.2011.615318","journal-title":"Clin Toxicol"},{"issue":"1","key":"1513_CR81","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/BF00401468","volume":"22","author":"ID Hirschhorn","year":"1971","unstructured":"Hirschhorn ID, Winter JC (1971) Mescaline and lysergic acid diethylamide (LSD) as discriminative stimuli. Psychopharmacologia 22(1):64\u201371","journal-title":"Psychopharmacologia"},{"key":"1513_CR82","volume-title":"LSD: My problem child","author":"A Hofmann","year":"1976","unstructured":"Hofmann A (1976) LSD: My problem child. McGraw Hill, New York"},{"key":"1513_CR83","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1146\/annurev.me.15.020164.001223","volume":"15","author":"LE Hollister","year":"1964","unstructured":"Hollister LE (1964) Chemical Psychoses. Annu Rev Med 15:203\u2013214. doi: 10.1146\/annurev.me.15.020164.001223","journal-title":"Annu Rev Med"},{"issue":"3131","key":"1513_CR84","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1126\/science.120.3131.1100","volume":"120","author":"A Horita","year":"1954","unstructured":"Horita A, Dille JM (1954) Pyretogenic effect of lysergic acid diethylamide. Science 120(3131):1100\u20131101","journal-title":"Science"},{"issue":"2","key":"1513_CR85","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0022-3565(25)11955-1","volume":"122","author":"A Horita","year":"1958","unstructured":"Horita A, Gogerty JH (1958) The pyretogenic effect of 5-hydroxytryptophan and its comparison with that of LSD. J Pharmacol Exp Ther 122(2):195\u2013200","journal-title":"J Pharmacol Exp Ther"},{"key":"1513_CR86","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0006-2952(61)90124-1","volume":"7","author":"A Horita","year":"1961","unstructured":"Horita A, Weber LJ (1961) The enzymic dephosphorylation and oxidation of psilocybin and psilocin by mammalian tissue homogenates. Biochem Pharmacol 7:47\u201354","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"1513_CR87","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/jlac.19355200104","volume":"520","author":"T Hoshino","year":"1935","unstructured":"Hoshino T, Shimodaira K (1935) Synthese des Bufotenins und \u00fcber 3-Methyl-3-\u03b2-oxy\u00e4thyl-indolenin. Synthesen in der Indol-Gruppe. XIV. Justus Liebigs Annalen der Chemie 520(1):19\u201330. doi: 10.1002\/jlac.19355200104","journal-title":"Justus Liebigs Annalen der Chemie"},{"issue":"4","key":"1513_CR88","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1176\/appi.ajp.162.4.815","volume":"162","author":"A Ikeda","year":"2005","unstructured":"Ikeda A, Sekiguchi K, Fujita K, Yamadera H, Koga Y (2005) 5-methoxy-N,N-diisopropyltryptamine-induced flashbacks. Am J Psychiatry 162(4):815. doi: 10.1176\/appi.ajp.162.4.815","journal-title":"Am J Psychiatry"},{"key":"1513_CR89","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF00408109","volume":"1","author":"H Isbell","year":"1959","unstructured":"Isbell H (1959) Comparison of the reactions induced by psilocybin and LSD-25 in man. Psychopharmacologia 1:29\u201338","journal-title":"Psychopharmacologia"},{"issue":"2","key":"1513_CR90","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1440-1819.2007.01638.x","volume":"61","author":"M Itokawa","year":"2007","unstructured":"Itokawa M, Iwata K, Takahashi M et al (2007) Acute confusional state after designer tryptamine abuse. Psychiatry Clin Neurosci 61(2):196\u2013199. doi: 10.1111\/j.1440-1819.2007.01638.x","journal-title":"Psychiatry Clin Neurosci"},{"issue":"3","key":"1513_CR91","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/1556-4029.12367","volume":"59","author":"A Jovel","year":"2014","unstructured":"Jovel A, Felthous A, Bhattacharyya A (2014) Delirium due to intoxication from the novel synthetic tryptamine 5-MeO-DALT. J Forensic Sci 59(3):844\u2013846. doi: 10.1111\/1556-4029.12367","journal-title":"J Forensic Sci"},{"issue":"2","key":"1513_CR92","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1124\/dmd.105.005835","volume":"34","author":"T Kamata","year":"2006","unstructured":"Kamata T, Katagi M, Kamata HT et al (2006) Metabolism of the psychotomimetic tryptamine derivative 5-methoxy-N,N-diisopropyltryptamine in humans: identification and quantification of its urinary metabolites. Drug Metab Dispos 34(2):281\u2013287. doi: 10.1124\/dmd.105.005835","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"1513_CR93","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11419-009-0087-9","volume":"28","author":"T Kamata","year":"2010","unstructured":"Kamata T, Katagi M, Tsuchihashi H (2010) Metabolism and toxicological analyses of hallucinogenic tryptamine analogues being abused in Japan. Forensic Toxicol 28(1):1\u20138. doi: 10.1007\/s11419-009-0087-9","journal-title":"Forensic Toxicol"},{"issue":"4","key":"1513_CR94","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1248\/jhs.52.425","volume":"52","author":"T Kanamori","year":"2006","unstructured":"Kanamori T, Kuwayama K, Tsujikawa K et al (2006) In vivo metabolism of 5-methoxy-N,N-diisopropyltryptamine in rat. J Health Sci 52(4):425\u2013430","journal-title":"J Health Sci"},{"issue":"3","key":"1513_CR95","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00421376","volume":"38","author":"J Kaplan","year":"1974","unstructured":"Kaplan J, Mandel LR, Stillman R et al (1974) Blood and urine levels of N,N-dimethyltryptamine following administration of psychoactive dosages to human subjects. Psychopharmacologia 38(3):239\u2013245","journal-title":"Psychopharmacologia"},{"key":"1513_CR96","first-page":"303","volume":"20","author":"M Katagi","year":"2002","unstructured":"Katagi M, Tsutsumi H, Miki A, Nakajima K, Tsuchihashi H (2002) Analysis of clandestine tablets of amphetamines and their related designer drugs encountered in recent Japan. Jpn J Forensic Toxicol 20:303\u2013319","journal-title":"Jpn J Forensic Toxicol"},{"issue":"2","key":"1513_CR97","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.toxlet.2014.06.020","volume":"229","author":"DP Katz","year":"2014","unstructured":"Katz DP, Bhattacharya D, Bhattacharya S et al (2014) Synthetic cathinones: \u201ca khat and mouse game\u201d. Toxicol Lett 229(2):349\u2013356. doi: 10.1016\/j.toxlet.2014.06.020","journal-title":"Toxicol Lett"},{"issue":"1","key":"1513_CR98","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jchromb.2005.01.041","volume":"825","author":"R Kikura-Hanajiri","year":"2005","unstructured":"Kikura-Hanajiri R, Hayashi M, Saisho K, Goda Y (2005) Simultaneous determination of nineteen hallucinogenic tryptamines\/beta-calbolines and phenethylamines using gas chromatography-mass spectrometry and liquid chromatography-electrospray ionisation-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 825(1):29\u201337. doi: 10.1016\/j.jchromb.2005.01.041","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"1","key":"1513_CR99","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1006\/abbi.1996.9771","volume":"337","author":"H Kim","year":"1997","unstructured":"Kim H, Sablin SO, Ramsay RR (1997) Inhibition of monoamine oxidase A by beta-carboline derivatives. Arch Biochem Biophys 337(1):137\u2013142. doi: 10.1006\/abbi.1996.9771","journal-title":"Arch Biochem Biophys"},{"issue":"3","key":"1513_CR100","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1080\/02791072.2011.605699","volume":"43","author":"A Kjellgren","year":"2011","unstructured":"Kjellgren A, Soussan C (2011) Heaven and hell\u2014a phenomenological study of recreational use of 4-HO-MET in Sweden. J Psychoact Drugs 43(3):211\u2013219","journal-title":"J Psychoact Drugs"},{"issue":"7","key":"1513_CR101","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1093\/jat\/24.7.550","volume":"24","author":"KL Klette","year":"2000","unstructured":"Klette KL, Anderson CJ, Poch GK, Nimrod AC, ElSohly MA (2000) Metabolism of lysergic acid diethylamide (LSD) to 2-oxo-3-hydroxy LSD (O-H-LSD) in human liver microsomes and cryopreserved human hepatocytes. J Anal Toxicol 24(7):550\u2013556","journal-title":"J Anal Toxicol"},{"issue":"2","key":"1513_CR102","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/BF00435266","volume":"76","author":"J Koerner","year":"1982","unstructured":"Koerner J, Appel JB (1982) Psilocybin as a discriminative stimulus: lack of specificity in an animal behavior model for \u2018hallucinogens\u2019. Psychopharmacology 76(2):130\u2013135","journal-title":"Psychopharmacology"},{"issue":"2","key":"1513_CR103","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/BF02245712","volume":"113","author":"KM Krebs","year":"1993","unstructured":"Krebs KM, Geyer MA (1993) Behavioral characterization of alpha-ethyltryptamine, a tryptamine derivative with MDMA-like properties in rats. Psychopharmacology 113(2):284\u2013287","journal-title":"Psychopharmacology"},{"key":"1513_CR104","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jfda.2013.09.003","volume":"21","author":"S-F Lee","year":"2013","unstructured":"Lee S-F, Hsu J, Tsay W-I (2013) The trend of drug abuse in Taiwan during the years 1999 to 2011. J Food Drug Anal 21:390\u2013396","journal-title":"J Food Drug Anal"},{"issue":"4","key":"1513_CR105","first-page":"160","volume":"63","author":"M Leino","year":"1985","unstructured":"Leino M, Airaksinen MM (1985) Methoxyindoles of the retina. Med Biol 63(4):160\u2013169","journal-title":"Med Biol"},{"key":"1513_CR106","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1476-5381.1965.tb02079.x","volume":"24","author":"AW Lessin","year":"1965","unstructured":"Lessin AW, Long RF, Parkes MW (1965) Central Stimulant Actions of Alpha-Alkyl Substituted Tryptamines in Mice. Br J Pharmacol Chemother 24:49\u201367","journal-title":"Br J Pharmacol Chemother"},{"issue":"2","key":"1513_CR107","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1124\/jpet.107.130625","volume":"324","author":"JX Li","year":"2008","unstructured":"Li JX, Rice KC, France CP (2008) Discriminative stimulus effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane in rhesus monkeys. J Pharmacol Exp Ther 324(2):827\u2013833. doi: 10.1124\/jpet.107.130625","journal-title":"J Pharmacol Exp Ther"},{"key":"1513_CR108","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1139\/cjr31-097","volume":"5","author":"R Manske","year":"1931","unstructured":"Manske R (1931) A synthesis of the methyltryptamines and some derivatives. Can J Res 5:592\u2013600","journal-title":"Can J Res"},{"issue":"3","key":"1513_CR109","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S0022-3565(25)20792-3","volume":"278","author":"GJ Marek","year":"1996","unstructured":"Marek GJ, Aghajanian GK (1996) LSD and the phenethylamine hallucinogen are potent partial agonists at 5-HT2A receptors on interneurons in rat piriform cortex. J Pharmacol Exp Ther 278(3):1373\u20131382","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"1513_CR110","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00213-005-2183-9","volume":"180","author":"D Marona-Lewicka","year":"2005","unstructured":"Marona-Lewicka D, Thisted RA, Nichols DE (2005) Distinct temporal phases in the behavioral pharmacology of LSD: dopamine D2 receptor-mediated effects in the rat and implications for psychosis. Psychopharmacology 180(3):427\u2013435. doi: 10.1007\/s00213-005-2183-9","journal-title":"Psychopharmacology"},{"issue":"1","key":"1513_CR111","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2492\/inflammregen.29.47","volume":"29","author":"Y Matsushima","year":"2009","unstructured":"Matsushima Y, Eguchi F, Kikukawa T, Matsuda T (2009) Historical overview of psychoactive mushrooms. Inflamm Regen 29(1):47\u201358","journal-title":"Inflamm Regen"},{"key":"1513_CR112","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.drugalcdep.2013.09.011","volume":"134","author":"JC Maxwell","year":"2014","unstructured":"Maxwell JC (2014) Psychoactive substances\u2013some new, some old: a scan of the situation in the U.S. Drug Alcohol Depend 134:71\u201377. doi: 10.1016\/j.drugalcdep.2013.09.011","journal-title":"Drug Alcohol Depend"},{"issue":"9","key":"1513_CR113","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/bmc.1551","volume":"25","author":"EH McIlhenny","year":"2011","unstructured":"McIlhenny EH, Riba J, Barbanoj MJ, Strassman R, Barker SA (2011) Methodology for and the determination of the major constituents and metabolites of the Amazonian botanical medicine ayahuasca in human urine. Biomed Chromatogr 25(9):970\u2013984. doi: 10.1002\/bmc.1551","journal-title":"Biomed Chromatogr"},{"issue":"3","key":"1513_CR114","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/bmc.1657","volume":"26","author":"EH McIlhenny","year":"2012","unstructured":"McIlhenny EH, Riba J, Barbanoj MJ, Strassman R, Barker SA (2012) Methodology for determining major constituents of ayahuasca and their metabolites in blood. Biomed Chromatogr 26(3):301\u2013313. doi: 10.1002\/bmc.1657","journal-title":"Biomed Chromatogr"},{"issue":"2","key":"1513_CR115","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.pharmthera.2004.03.002","volume":"102","author":"DJ McKenna","year":"2004","unstructured":"McKenna DJ (2004) Clinical investigations of the therapeutic potential of ayahuasca: rationale and regulatory challenges. Pharmacol Ther 102(2):111\u2013129. doi: 10.1016\/j.pharmthera.2004.03.002","journal-title":"Pharmacol Ther"},{"issue":"2","key":"1513_CR116","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0378-8741(84)90003-5","volume":"10","author":"DJ McKenna","year":"1984","unstructured":"McKenna DJ, Towers GH, Abbott F (1984) Monoamine oxidase inhibitors in South American hallucinogenic plants: tryptamine and beta-carboline constituents of ayahuasca. J Ethnopharmacol 10(2):195\u2013223","journal-title":"J Ethnopharmacol"},{"issue":"3","key":"1513_CR117","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0028-3908(90)90001-8","volume":"29","author":"DJ McKenna","year":"1990","unstructured":"McKenna DJ, Repke DB, Lo L, Peroutka SJ (1990) Differential interactions of indolealkylamines with 5-hydroxytryptamine receptor subtypes. Neuropharmacology 29(3):193\u2013198","journal-title":"Neuropharmacology"},{"issue":"5","key":"1513_CR118","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/jat\/27.5.313","volume":"27","author":"R Meatherall","year":"2003","unstructured":"Meatherall R, Sharma P (2003) Foxy, a designer tryptamine hallucinogen. J Anal Toxicol 27(5):313\u2013317","journal-title":"J Anal Toxicol"},{"issue":"4","key":"1513_CR119","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1080\/02791072.1998.10399709","volume":"30","author":"R Metzner","year":"1998","unstructured":"Metzner R (1998) Hallucinogenic drugs and plants in psychotherapy and shamanism. J Psychoact Drugs 30(4):333\u2013341. doi: 10.1080\/02791072.1998.10399709","journal-title":"J Psychoact Drugs"},{"issue":"1","key":"1513_CR120","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF02316866","volume":"105","author":"SM Mittman","year":"1991","unstructured":"Mittman SM, Geyer MA (1991) Dissociation of multiple effects of acute LSD on exploratory behavior in rats by ritanserin and propranolol. Psychopharmacology 105(1):69\u201376","journal-title":"Psychopharmacology"},{"issue":"6","key":"1513_CR121","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s00204-013-1057-x","volume":"87","author":"MS Monteiro","year":"2013","unstructured":"Monteiro MS, Bastos ML, de Pinho PG, Carvalho M (2013) Update on 1-benzylpiperazine (BZP) party pills. Arch Toxicol 87(6):929\u2013947. doi: 10.1007\/s00204-013-1057-x","journal-title":"Arch Toxicol"},{"issue":"2","key":"1513_CR122","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jep.2005.12.022","volume":"106","author":"C Moretti","year":"2006","unstructured":"Moretti C, Gaillard Y, Grenand P, Bevalot F, Prevosto JM (2006) Identification of 5-hydroxy-tryptamine (bufotenine) in takini (Brosimumacutifolium Huber subsp. acutifolium C.C. Berg, Moraceae), a shamanic potion used in the Guiana Plateau. J Ethnopharmacol 106(2):198\u2013202. doi: 10.1016\/j.jep.2005.12.022","journal-title":"J Ethnopharmacol"},{"issue":"5","key":"1513_CR123","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.jen.2004.07.037","volume":"30","author":"AA Muller","year":"2004","unstructured":"Muller AA (2004) New drugs of abuse update: foxy Methoxy. J Emerg Nurs 30(5):507\u2013508. doi: 10.1016\/j.jen.2004.07.037","journal-title":"J Emerg Nurs"},{"issue":"7","key":"1513_CR124","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/phar.1424","volume":"34","author":"ME Musselman","year":"2014","unstructured":"Musselman ME, Hampton JP (2014) \u201cNot for human consumption\u201d: a review of emerging designer drugs. Pharmacotherapy 34(7):745\u2013757. doi: 10.1002\/phar.1424","journal-title":"Pharmacotherapy"},{"issue":"2","key":"1513_CR125","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0378-4347(96)00106-5","volume":"683","author":"F Musshoff","year":"1996","unstructured":"Musshoff F, Daldrup T, Bonte W, Leitner A, Lesch OM (1996) Formaldehyde-derived tetrahydroisoquinolines and tetrahydro-beta-carbolines in human urine. J Chromatogr B Biomed Appl 683(2):163\u2013176","journal-title":"J Chromatogr B Biomed Appl"},{"issue":"2\u20133","key":"1513_CR126","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejphar.2006.11.075","volume":"559","author":"F Nagai","year":"2007","unstructured":"Nagai F, Nonaka R, Satoh Hisashi Kamimura K (2007) The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain. Eur J Pharmacol 559(2\u20133):132\u2013137. doi: 10.1016\/j.ejphar.2006.11.075","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"1513_CR127","first-page":"9","volume":"3","author":"N Narasimhachari","year":"1971","unstructured":"Narasimhachari N, Heller B, Spaide J et al (1971) Urinary studies of schizophrenics and controls. Biol Psychiatry 3(1):9\u201320","journal-title":"Biol Psychiatry"},{"issue":"9","key":"1513_CR128","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.bcp.2006.01.015","volume":"71","author":"S Narimatsu","year":"2006","unstructured":"Narimatsu S, Yonemoto R, Saito K et al (2006) Oxidative metabolism of 5-methoxy-N,N-diisopropyltryptamine (Foxy) by human liver microsomes and recombinant cytochrome P450 enzymes. Biochem Pharmacol 71(9):1377\u20131385. doi: 10.1016\/j.bcp.2006.01.015","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"1513_CR129","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.bcp.2007.09.019","volume":"75","author":"S Narimatsu","year":"2008","unstructured":"Narimatsu S, Yonemoto R, Masuda K et al (2008) Oxidation of 5-methoxy-N,N-diisopropyltryptamine in rat liver microsomes and recombinant cytochrome P450 enzymes. Biochem Pharmacol 75(3):752\u2013760. doi: 10.1016\/j.bcp.2007.09.019","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"1513_CR130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.emc.2013.09.001","volume":"32","author":"ME Nelson","year":"2014","unstructured":"Nelson ME, Bryant SM, Aks SE (2014) Emerging drugs of abuse. Emerg Med Clin N Am 32(1):1\u201328. doi: 10.1016\/j.emc.2013.09.001","journal-title":"Emerg Med Clin N Am"},{"issue":"2","key":"1513_CR131","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.pharmthera.2003.11.002","volume":"101","author":"DE Nichols","year":"2004","unstructured":"Nichols DE (2004) Hallucinogens. Pharmacol Ther 101(2):131\u2013181. doi: 10.1016\/j.pharmthera.2003.11.002","journal-title":"Pharmacol Ther"},{"issue":"1","key":"1513_CR132","first-page":"20","volume":"23","author":"DE Nichols","year":"2013","unstructured":"Nichols DE (2013) Serotonin, and the past and future of LSD. MAPS Bull 23(1):20\u201323","journal-title":"MAPS Bull"},{"issue":"2","key":"1513_CR133","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1080\/02791072.1999.10471741","volume":"31","author":"J Ott","year":"1999","unstructured":"Ott J (1999) Pharmahuasca: human pharmacology of oral DMT plus harmine. J Psychoact Drugs 31(2):171\u2013177. doi: 10.1080\/02791072.1999.10471741","journal-title":"J Psychoact Drugs"},{"issue":"3","key":"1513_CR134","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/02791072.2001.10400574","volume":"33","author":"J Ott","year":"2001","unstructured":"Ott J (2001a) Pharmanopo-psychonautics: human intranasal, sublingual, intrarectal, pulmonary and oral pharmacology of bufotenine. J Psychoact Drugs 33(3):273\u2013281. doi: 10.1080\/02791072.2001.10400574","journal-title":"J Psychoact Drugs"},{"issue":"4","key":"1513_CR135","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1080\/02791072.2001.10399925","volume":"33","author":"J Ott","year":"2001","unstructured":"Ott J (2001b) Pharmepena-psychonautics: human intranasal, sublingual and oral pharmacology of 5-methoxy-N,N-dimethyl-tryptamine. J Psychoact Drugs 33(4):403\u2013407. doi: 10.1080\/02791072.2001.10399925","journal-title":"J Psychoact Drugs"},{"issue":"4","key":"1513_CR136","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0893-133X(01)00282-2","volume":"25","author":"A Ouagazzal","year":"2001","unstructured":"Ouagazzal A, Grottick AJ, Moreau J, Higgins GA (2001) Effect of LSD on prepulse inhibition and spontaneous behavior in the rat. A pharmacological analysis and comparison between two rat strains. Neuropsychopharmacology 25(4):565\u2013575. doi: 10.1016\/S0893-133X(01)00282-2","journal-title":"Neuropsychopharmacology"},{"issue":"671","key":"1513_CR137","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1136\/pgmj.57.671.543","volume":"57","author":"NR Peden","year":"1981","unstructured":"Peden NR, Bissett AF, Macaulay KE, Crooks J, Pelosi AJ (1981) Clinical toxicology of \u201cmagic mushroom\u201d ingestion. Postgrad Med J 57(671):543\u2013545","journal-title":"Postgrad Med J"},{"issue":"1","key":"1513_CR138","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/BF00443425","volume":"97","author":"PA Pierce","year":"1989","unstructured":"Pierce PA, Peroutka SJ (1989) Hallucinogenic drug interactions with neurotransmitter receptor binding sites in human cortex. Psychopharmacology 97(1):118\u2013122","journal-title":"Psychopharmacology"},{"issue":"1","key":"1513_CR139","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0378-4347(98)00574-X","volume":"724","author":"GK Poch","year":"1999","unstructured":"Poch GK, Klette KL, Hallare DA et al (1999) Detection of metabolites of lysergic acid diethylamide (LSD) in human urine specimens: 2-oxo-3-hydroxy-LSD, a prevalent metabolite of LSD. J Chromatogr B Biomed Sci Appl 724(1):23\u201333","journal-title":"J Chromatogr B Biomed Sci Appl"},{"issue":"3","key":"1513_CR140","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/jat\/24.3.170","volume":"24","author":"GK Poch","year":"2000","unstructured":"Poch GK, Klette KL, Anderson C (2000) The quantitation of 2-oxo-3-hydroxy lysergic acid diethylamide (O-H-LSD) in human urine specimens, a metabolite of LSD: comparative analysis using liquid chromatography-selected ion monitoring mass spectrometry and liquid chromatography-ion trap mass spectrometry. J Anal Toxicol 24(3):170\u2013179","journal-title":"J Anal Toxicol"},{"issue":"1","key":"1513_CR141","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s13181-011-0193-z","volume":"8","author":"JM Prosser","year":"2012","unstructured":"Prosser JM, Nelson LS (2012) The toxicology of bath salts: a review of synthetic cathinones. J Med Toxicol 8(1):33\u201342. doi: 10.1007\/s13181-011-0193-z","journal-title":"J Med Toxicol"},{"issue":"10","key":"1513_CR142","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/qjmed\/hcq132","volume":"103","author":"J Ramsey","year":"2010","unstructured":"Ramsey J, Dargan PI, Smyllie M et al (2010) Buying \u2018legal\u2019 recreational drugs does not mean that you are not breaking the law. QJM 103(10):777\u2013783. doi: 10.1093\/qjmed\/hcq132","journal-title":"QJM"},{"issue":"1\u20132","key":"1513_CR143","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0378-4347(99)00189-9","volume":"733","author":"SA Reuschel","year":"1999","unstructured":"Reuschel SA, Eades D, Foltz RL (1999) Recent advances in chromatographic and mass spectrometric methods for determination of LSD and its metabolites in physiological specimens. J Chromatogr B Biomed Sci Appl 733(1\u20132):145\u2013159","journal-title":"J Chromatogr B Biomed Sci Appl"},{"issue":"7\u20138","key":"1513_CR144","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/dta.1344","volume":"4","author":"J Riba","year":"2012","unstructured":"Riba J, McIlhenny EH, Valle M, Bouso JC, Barker SA (2012) Metabolism and disposition of N,N-dimethyltryptamine and harmala alkaloids after oral administration of ayahuasca. Drug Test Anal 4(7\u20138):610\u2013616. doi: 10.1002\/dta.1344","journal-title":"Drug Test Anal"},{"key":"1513_CR145","author":"J Riba","year":"2014","unstructured":"Riba J, McIlhenny EH, Bouso JC, Barker SA (2014) Metabolism and urinary disposition of N,N-dimethyltryptamine after oral and smoked administration: a comparative study. Drug Test Anal. doi: 10.1002\/dta.1685","journal-title":"Drug Test Anal"},{"issue":"2","key":"1513_CR146","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF02860772","volume":"26","author":"L Rivier","year":"1972","unstructured":"Rivier L, Lindgren J-E (1972) \u201cAyahuasca\u201d, the South American hallucinogenic drink: an ethnobotanical and chemical investigation. Econ Bot 26(2):101\u2013129. doi: 10.1007\/BF02860772","journal-title":"Econ Bot"},{"issue":"10","key":"1513_CR147","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1523\/JNEUROSCI.01-10-01148.1981","volume":"1","author":"MA Rogawski","year":"1981","unstructured":"Rogawski MA, Aghajanian GK (1981) Serotonin autoreceptors on dorsal raphe neurons: structure-activity relationships of tryptamine analogs. J Neurosci 1(10):1148\u20131154","journal-title":"J Neurosci"},{"issue":"9","key":"1513_CR148","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.2042-7158.1957.tb12312.x","volume":"9","author":"E Rothlin","year":"1957","unstructured":"Rothlin E (1957) Pharmacology of lysergic acid diethylamide and some of its related compounds. J Pharm Pharmacol 9(9):569\u2013587","journal-title":"J Pharm Pharmacol"},{"issue":"2","key":"1513_CR149","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/S0022-3565(25)12371-9","volume":"276","author":"KE Sabol","year":"1996","unstructured":"Sabol KE, Lew R, Richards JB, Vosmer GL, Seiden LS (1996) Methylenedioxymethamphetamine-induced serotonin deficits are followed by partial recovery over a 52-week period. Part I: synaptosomal uptake and tissue concentrations. J Pharmacol Exp Ther 276(2):846\u2013854","journal-title":"J Pharmacol Exp Ther"},{"issue":"3\u20134","key":"1513_CR150","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1080\/00952990701202970","volume":"43","author":"B Sanders","year":"2008","unstructured":"Sanders B, Lankenau SE, Bloom JJ, Hathazi D (2008) \u201cResearch chemicals\u201d: tryptamine and phenethylamine use among high-risk youth. Subst Use Misuse 43(3\u20134):389\u2013402. doi: 10.1080\/00952990701202970","journal-title":"Subst Use Misuse"},{"issue":"3","key":"1513_CR151","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/S0022-3565(25)10168-7","volume":"264","author":"CR Scanzello","year":"1993","unstructured":"Scanzello CR, Hatzidimitriou G, Martello AL, Katz JL, Ricaurte GA (1993) Serotonergic recovery after (\u00b1)3,4-(methylenedioxy) methamphetamine injury: observations in rats. J Pharmacol Exp Ther 264(3):1484\u20131491","journal-title":"J Pharmacol Exp Ther"},{"issue":"1\u20133","key":"1513_CR152","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.forsciint.2010.06.030","volume":"206","author":"MM Schmidt","year":"2011","unstructured":"Schmidt MM, Sharma A, Schifano F, Feinmann C (2011) \u201cLegal highs\u201d on the net-Evaluation of UK-based Websites, products and product information. Forensic Sci Int 206(1\u20133):92\u201397. doi: 10.1016\/j.forsciint.2010.06.030","journal-title":"Forensic Sci Int"},{"issue":"1","key":"1513_CR153","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0014-2999(94)90643-2","volume":"264","author":"R Schreiber","year":"1994","unstructured":"Schreiber R, Brocco M, Millan MJ (1994) Blockade of the discriminative stimulus effects of by MDL 100,907 and the \u2018atypical\u2019 antipsychotics, clozapine and risperidone. Eur J Pharmacol 264(1):99\u2013102","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"1513_CR154","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1177\/000992288802700202","volume":"27","author":"RH Schwartz","year":"1988","unstructured":"Schwartz RH, Smith DE (1988) Hallucinogenic mushrooms. Clin Pediatr 27(2):70\u201373","journal-title":"Clin Pediatr"},{"issue":"2","key":"1513_CR155","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.pnpbp.2012.04.017","volume":"39","author":"KA Seely","year":"2012","unstructured":"Seely KA, Lapoint J, Moran JH, Fattore L (2012) Spice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoids. Prog Neuropsychopharmacol Biol Psychiatry 39(2):234\u2013243. doi: 10.1016\/j.pnpbp.2012.04.017","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"3","key":"1513_CR156","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0024-3205(77)90383-6","volume":"20","author":"MH Sheard","year":"1977","unstructured":"Sheard MH, Astrachan DI, Davis M (1977) The effect of D-lysergic acid diethylamide (LSD) upon shock elicited fighting in rats. Life Sci 20(3):427\u2013430","journal-title":"Life Sci"},{"issue":"8","key":"1513_CR157","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2174\/138920010794233495","volume":"11","author":"HW Shen","year":"2010","unstructured":"Shen HW, Jiang XL, Winter JC, Yu AM (2010) Psychedelic 5-methoxy-N,N-dimethyltryptamine: metabolism, pharmacokinetics, drug interactions, and pharmacological actions. Curr Drug Metab 11(8):659\u2013666","journal-title":"Curr Drug Metab"},{"issue":"1","key":"1513_CR158","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.pnpbp.2006.06.012","volume":"31","author":"E Shimizu","year":"2007","unstructured":"Shimizu E, Watanabe H, Kojima T et al (2007) Combined intoxication with methylone and 5-MeO-MIPT. Prog Neuropsychopharmacol Biol Psychiatry 31(1):288\u2013291. doi: 10.1016\/j.pnpbp.2006.06.012","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"1513_CR159","volume-title":"TIHKAL: the continuation","author":"AT Shulgin","year":"1997","unstructured":"Shulgin AT, Shulgin A (1997) TIHKAL: the continuation. Transform, Berkeley"},{"issue":"20","key":"1513_CR160","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1016\/0006-2952(79)90618-X","volume":"28","author":"ZH Siddik","year":"1979","unstructured":"Siddik ZH, Barnes RD, Dring LG, Smith RL, Williams RT (1979) The fate of lysergic acid DI[14C]ethylamide ([14C]LSD) in the rat, guinea pig and rhesus monkey and of [14C]iso-LSD in rat. Biochem Pharmacol 28(20):3093\u20133101","journal-title":"Biochem Pharmacol"},{"issue":"10","key":"1513_CR161","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/0006-3223(90)90566-K","volume":"28","author":"BR Sitaram","year":"1990","unstructured":"Sitaram BR, McLeod WR (1990) Observations on the metabolism of the psychotomimetic indolealkylamines: implications for future clinical studies. Biol Psychiatry 28(10):841\u2013848","journal-title":"Biol Psychiatry"},{"issue":"13","key":"1513_CR162","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1016\/0006-2952(87)90159-6","volume":"36","author":"BR Sitaram","year":"1987","unstructured":"Sitaram BR, Lockett L, Blackman GL, McLeod WR (1987a) Urinary excretion of 5-methoxy-N,N-dimethyltryptamine, N,N-dimethyltryptamine and their N-oxides in the rat. Biochem Pharmacol 36(13):2235\u20132237","journal-title":"Biochem Pharmacol"},{"issue":"9","key":"1513_CR163","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/0006-2952(87)90118-3","volume":"36","author":"BR Sitaram","year":"1987","unstructured":"Sitaram BR, Lockett L, Talomsin R, Blackman GL, McLeod WR (1987b) In vivo metabolism of 5-methoxy-N,N-dimethyltryptamine and N,N-dimethyltryptamine in the rat. Biochem Pharmacol 36(9):1509\u20131512","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"1513_CR164","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00213-009-1459-x","volume":"204","author":"MR Skelton","year":"2009","unstructured":"Skelton MR, Schaefer TL, Herring NR, Grace CE, Vorhees CV, Williams MT (2009) Comparison of the developmental effects of 5-methoxy-N,N-diisopropyltryptamine (Foxy) to (\u00b1)-3,4-methylenedioxymethamphetamine (ecstasy) in rats. Psychopharmacology 204(2):287\u2013297. doi: 10.1007\/s00213-009-1459-x","journal-title":"Psychopharmacology"},{"issue":"7","key":"1513_CR165","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/jat\/24.7.543","volume":"24","author":"JH Sklerov","year":"2000","unstructured":"Sklerov JH, Magluilo J Jr, Shannon KK, Smith ML (2000) Liquid chromatography-electrospray ionization mass spectrometry for the detection of lysergide and a major metabolite, 2-oxo-3-hydroxy-LSD, in urine and blood. J Anal Toxicol 24(7):543\u2013549","journal-title":"J Anal Toxicol"},{"issue":"8","key":"1513_CR166","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1093\/jat\/29.8.838","volume":"29","author":"J Sklerov","year":"2005","unstructured":"Sklerov J, Levine B, Moore KA, King T, Fowler D (2005) A fatal intoxication following the ingestion of 5-methoxy-N,N-dimethyltryptamine in an ayahuasca preparation. J Anal Toxicol 29(8):838\u2013841","journal-title":"J Anal Toxicol"},{"issue":"3","key":"1513_CR167","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0091-3057(98)00110-5","volume":"61","author":"RL Smith","year":"1998","unstructured":"Smith RL, Canton H, Barrett RJ, Sanders-Bush E (1998) Agonist properties of N,N-dimethyltryptamine at serotonin 5-HT2A and 5-HT2C receptors. Pharmacol Biochem Behav 61(3):323\u2013330","journal-title":"Pharmacol Biochem Behav"},{"issue":"3","key":"1513_CR168","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s002130051000","volume":"144","author":"RL Smith","year":"1999","unstructured":"Smith RL, Barrett RJ, Sanders-Bush E (1999) Mechanism of tolerance development to 2,5-dimethoxy-4-iodoamphetamine in rats: down-regulation of the 5-HT2A, but not 5-HT2C, receptor. Psychopharmacology 144(3):248\u2013254","journal-title":"Psychopharmacology"},{"issue":"1","key":"1513_CR169","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00213-002-1252-6","volume":"166","author":"RL Smith","year":"2003","unstructured":"Smith RL, Barrett RJ, Sanders-Bush E (2003) Discriminative stimulus properties of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane [(\u00b1)DOI] in C57BL\/6J mice. Psychopharmacology 166(1):61\u201368. doi: 10.1007\/s00213-002-1252-6","journal-title":"Psychopharmacology"},{"issue":"1","key":"1513_CR170","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/02791072.2014.873684","volume":"46","author":"DE Smith","year":"2014","unstructured":"Smith DE, Raswyck GE, Davidson LD (2014) From Hofmann to the Haight Ashbury, and into the future: the past and potential of lysergic acid diethylamide. J Psychoact Drugs 46(1):3\u201310. doi: 10.1080\/02791072.2014.873684","journal-title":"J Psychoact Drugs"},{"issue":"1","key":"1513_CR171","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/BF03160901","volume":"1","author":"SC Smolinske","year":"2005","unstructured":"Smolinske SC, Rastogi R, Schenkel S (2005) Foxy methoxy: a new drug of abuse. J Med Toxicol 1(1):22\u201325","journal-title":"J Med Toxicol"},{"issue":"1\u20133","key":"1513_CR172","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0379-0738(00)00213-9","volume":"113","author":"G Sticht","year":"2000","unstructured":"Sticht G, Kaferstein H (2000) Detection of psilocin in body fluids. Forensic Sci Int 113(1\u20133):403\u2013407","journal-title":"Forensic Sci Int"},{"key":"1513_CR173","unstructured":"Strassman RJ (2001) DMT: the spirit molecule: a doctor's revolutionary research into the biology of near-death and mystical experiences. Park Street Press, Rochester"},{"issue":"2","key":"1513_CR174","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1001\/archpsyc.1994.03950020009001","volume":"51","author":"RJ Strassman","year":"1994","unstructured":"Strassman RJ, Qualls CR (1994) Dose-response study of N,N-dimethyltryptamine in humans. I. Neuroendocrine, autonomic, and cardiovascular effects. Arch Gen Psychiatry 51(2):85\u201397","journal-title":"Arch Gen Psychiatry"},{"issue":"2","key":"1513_CR175","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1001\/archpsyc.1994.03950020022002","volume":"51","author":"RJ Strassman","year":"1994","unstructured":"Strassman RJ, Qualls CR, Uhlenhuth EH, Kellner R (1994) Dose-response study of N,N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale. Arch Gen Psychiatry 51(2):98\u2013108","journal-title":"Arch Gen Psychiatry"},{"issue":"9","key":"1513_CR176","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/0006-3223(95)00200-6","volume":"39","author":"RJ Strassman","year":"1996","unstructured":"Strassman RJ, Qualls CR, Berg LM (1996) Differential tolerance to biological and subjective effects of four closely spaced doses of N,N-dimethyltryptamine in humans. Biol Psychiatry 39(9):784\u2013795. doi: 10.1016\/0006-3223(95)00200-6","journal-title":"Biol Psychiatry"},{"issue":"11","key":"1513_CR177","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/BF02157378","volume":"12","author":"S Szara","year":"1956","unstructured":"Szara S (1956) Dimethyltryptamin: its metabolism in man; the relation to its psychotic effect to the serotonin metabolism. Experientia 12(11):441\u2013442","journal-title":"Experientia"},{"issue":"9","key":"1513_CR178","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00787-012-0282-9","volume":"21","author":"J Taljemark","year":"2012","unstructured":"Taljemark J, Johansson BA (2012) Drug-induced acute psychosis in an adolescent first-time user of 4-HO-MET. Eur Child Adolesc Psychiatry 21(9):527\u2013528. doi: 10.1007\/s00787-012-0282-9","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"1\u20132","key":"1513_CR179","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.forsciint.2005.11.026","volume":"163","author":"E Tanaka","year":"2006","unstructured":"Tanaka E, Kamata T, Katagi M, Tsuchihashi H, Honda K (2006) A fatal poisoning with 5-methoxy-N,N-diisopropyltryptamine, Foxy. Forensic Sci Int 163(1\u20132):152\u2013154. doi: 10.1016\/j.forsciint.2005.11.026","journal-title":"Forensic Sci Int"},{"issue":"2","key":"1513_CR180","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/BF00176847","volume":"94","author":"M Titeler","year":"1988","unstructured":"Titeler M, Lyon RA, Glennon RA (1988) Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens. Psychopharmacology 94(2):213\u2013216","journal-title":"Psychopharmacology"},{"issue":"2","key":"1513_CR181","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/oxfordjournals.alcalc.a008132","volume":"31","author":"H Tsuchiya","year":"1996","unstructured":"Tsuchiya H, Yamada K, Tajima K, Hayashi T (1996) Urinary excretion of tetrahydro-beta-carbolines relating to ingestion of alcoholic beverages. Alcohol Alcohol 31(2):197\u2013203","journal-title":"Alcohol Alcohol"},{"key":"1513_CR182","volume-title":"The essential psychadelic handbook","author":"DM Turner","year":"1994","unstructured":"Turner DM (1994) The essential psychadelic handbook. Panther Press, San Francisco"},{"issue":"1","key":"1513_CR183","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1152\/ajplegacy.1953.175.1.157","volume":"175","author":"BM Twarog","year":"1953","unstructured":"Twarog BM, Page IH (1953) Serotonin content of some mammalian tissues and urine and a method for its determination. Am J Physiol 175(1):157\u2013161","journal-title":"Am J Physiol"},{"issue":"3","key":"1513_CR184","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.euroneuro.2013.12.006","volume":"24","author":"F Tyls","year":"2014","unstructured":"Tyls F, Palenicek T, Horacek J (2014) Psilocybin\u2014summary of knowledge and new perspectives. Eur Neuropsychopharmacol 24(3):342\u2013356. doi: 10.1016\/j.euroneuro.2013.12.006","journal-title":"Eur Neuropsychopharmacol"},{"issue":"1","key":"1513_CR185","first-page":"12","volume":"50","author":"I Ujvary","year":"2014","unstructured":"Ujvary I (2014) Psychoactive natural products: overview of recent developments. Ann Ist Super Sanita 50(1):12\u201327. doi: 10.4415\/ANN_14_01_04","journal-title":"Ann Ist Super Sanita"},{"issue":"1","key":"1513_CR186","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00204-013-1163-9","volume":"88","author":"MJ Valente","year":"2014","unstructured":"Valente MJ, de Pinho PG, Bastos ML, Carvalho F, Carvalho M (2014) Khat and synthetic cathinones: a review. Arch Toxicol 88(1):15\u201345. doi: 10.1007\/s00204-013-1163-9","journal-title":"Arch Toxicol"},{"issue":"6","key":"1513_CR187","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/jat\/28.6.407","volume":"28","author":"SP Vorce","year":"2004","unstructured":"Vorce SP, Sklerov JH (2004) A general screening and confirmation approach to the analysis of designer tryptamines and phenethylamines in blood and urine using GC\u2013EI\u2013MS and HPLC-electrospray-MS. J Anal Toxicol 28(6):407\u2013410","journal-title":"J Anal Toxicol"},{"issue":"4","key":"1513_CR188","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1016\/j.jfda.2013.09.030","volume":"21","author":"K Wada","year":"2013","unstructured":"Wada K, Funada M, Shimane T (2013) Current status of substance abuse and HIV infection in Japan. J Food Drug Anal 21(4):S33\u2013S36. doi: 10.1016\/j.jfda.2013.09.030","journal-title":"J Food Drug Anal"},{"issue":"1","key":"1513_CR189","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0091-3057(78)90016-3","volume":"9","author":"JK Walters","year":"1978","unstructured":"Walters JK, Sheard MH, Davis M (1978) Effects of N,N-dimethyltryptamine (DMT) and 5-methoxy-N,N-dimethyltryptamine (5-MeODMT) on shock elicited fighting in rats. Pharmacol Biochem Behav 9(1):87\u201390","journal-title":"Pharmacol Biochem Behav"},{"issue":"1\u20132","key":"1513_CR190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0378-8741(94)90051-5","volume":"41","author":"AT Weil","year":"1994","unstructured":"Weil AT, Davis W (1994) Bufo alvarius: a potent hallucinogen of animal origin. J Ethnopharmacol 41(1\u20132):1\u20138","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"1513_CR191","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jlac.19345130102","volume":"513","author":"H Wieland","year":"1934","unstructured":"Wieland H, Konz W, Mittasch H (1934) Die konstitution von Bufotenin und Bufotenidin. \u00dcber kr\u00f6ten-Giftstoffe. VII. Justus Liebigs Ann Chem 513(1):1\u201325","journal-title":"Justus Liebigs Ann Chem"},{"issue":"6","key":"1513_CR192","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1038\/sj.npp.1301232","volume":"32","author":"MT Williams","year":"2007","unstructured":"Williams MT, Herring NR, Schaefer TL et al (2007) Alterations in body temperature, corticosterone, and behavior following the administration of 5-methoxy-diisopropyltryptamine (\u2018foxy\u2019) to adult rats: a new drug of abuse. Neuropsychopharmacology 32(6):1404\u20131420. doi: 10.1038\/sj.npp.1301232","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"1513_CR193","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.forsciint.2004.04.017","volume":"148","author":"JM Wilson","year":"2005","unstructured":"Wilson JM, McGeorge F, Smolinske S, Meatherall R (2005) A foxy intoxication. Forensic Sci Int 148(1):31\u201336. doi: 10.1016\/j.forsciint.2004.04.017","journal-title":"Forensic Sci Int"},{"issue":"1","key":"1513_CR194","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/0269881113513852","volume":"28","author":"AR Winstock","year":"2014","unstructured":"Winstock AR, Kaar S, Borschmann R (2014) Dimethyltryptamine (DMT): prevalence, user characteristics and abuse liability in a large global sample. J Psychopharmacol 28(1):49\u201354. doi: 10.1177\/0269881113513852","journal-title":"J Psychopharmacol"},{"issue":"1","key":"1513_CR195","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0091-3057(99)00178-1","volume":"65","author":"JC Winter","year":"2000","unstructured":"Winter JC, Filipink RA, Timineri D, Helsley SE, Rabin RA (2000) The paradox of 5-methoxy-N,N-dimethyltryptamine: an indoleamine hallucinogen that induces stimulus control via 5-HT1A receptors. Pharmacol Biochem Behav 65(1):75\u201382","journal-title":"Pharmacol Biochem Behav"},{"issue":"2","key":"1513_CR196","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00213-003-1636-2","volume":"172","author":"JC Winter","year":"2004","unstructured":"Winter JC, Eckler JR, Rabin RA (2004) Serotonergic\/glutamatergic interactions: the effects of mGlu2\/3 receptor ligands in rats trained with LSD and PCP as discriminative stimuli. Psychopharmacology 172(2):233\u2013240. doi: 10.1007\/s00213-003-1636-2","journal-title":"Psychopharmacology"},{"issue":"4","key":"1513_CR197","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.pbb.2007.06.003","volume":"87","author":"JC Winter","year":"2007","unstructured":"Winter JC, Rice KC, Amorosi DJ, Rabin RA (2007) Psilocybin-induced stimulus control in the rat. Pharmacol Biochem Behav 87(4):472\u2013480. doi: 10.1016\/j.pbb.2007.06.003","journal-title":"Pharmacol Biochem Behav"},{"key":"1513_CR198","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00413101","volume":"3","author":"AB Wolbach Jr","year":"1962","unstructured":"Wolbach AB Jr, Isbell H, Miner EJ (1962) Cross tolerance between mescaline and LSD-25, with a comparison of the mescaline and LSD reactions. Psychopharmacologia 3:1\u201314","journal-title":"Psychopharmacologia"},{"issue":"1","key":"1513_CR199","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/BF02818560","volume":"47","author":"M Wurst","year":"2002","unstructured":"Wurst M, Kysilka R, Flieger M (2002) Psychoactive tryptamines from basidiomycetes. Folia Microbiol 47(1):3\u201327","journal-title":"Folia Microbiol"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-015-1513-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00204-015-1513-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-015-1513-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T15:14:17Z","timestamp":1747926857000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00204-015-1513-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,16]]},"references-count":199,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["1513"],"URL":"https:\/\/doi.org\/10.1007\/s00204-015-1513-x","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,16]]}}}